Core Member of China's Most Celebrated Liver Cancer Surgical Team
Fudan University Zhongshan Hospital is home to China's most internationally recognized liver cancer surgical program — led by Academician Fan Jia, whose team has set global benchmarks for liver cancer resection and transplantation outcomes. Dr. Sun Yunfan is a core member of this team, combining over 2,000 hepatobiliary surgical procedures with landmark research into the mechanisms of liver cancer metastasis and recurrence — the two factors that most determine long-term survival after surgery.
Featured Specialist: Dr. Sun Yunfan (孙云帆)
Dr. Sun Yunfan is Associate Chief Physician in the Department of Liver Surgery and Transplantation at Zhongshan Hospital, Fudan University (Fudan Daxue Fushu Zhongshan Yiyuan) — China's premier liver cancer surgical center. His credentials are exceptional:
- Core member of Academician Fan Jia's team — working directly within the surgical program of Prof. Fan Jia, one of China's most decorated surgeons and a member of the Chinese Academy of Sciences, whose liver cancer research and surgical outcomes are internationally recognized
- Shanghai Silver Snake Award (上海市銀蛇奖) First Prize — one of Shanghai's most prestigious awards for outstanding young medical scientists, recognizing exceptional clinical and research achievement
- Over 2,000 hepatobiliary surgical procedures performed as primary surgeon or first assistant — spanning the full spectrum of liver and biliary surgery
- Important discoveries in liver cancer metastasis and recurrence mechanisms — research that directly informs post-operative surveillance and adjuvant treatment strategies
The Fan Jia Team: China's Premier Liver Cancer Surgical Program
To understand the significance of Dr. Sun's position, it is important to understand the team he works within. Academician Fan Jia's liver surgery program at Zhongshan Hospital has:
- One of the largest liver cancer surgical volumes in the world
- Pioneered multiple surgical innovations in liver cancer resection and transplantation that are now standard practice in China
- Published landmark research in journals including Nature Medicine, Journal of Clinical Oncology, and Hepatology
- Established the Milan Criteria expansion protocols used in China for liver transplant eligibility
- Developed the "Hangzhou Criteria" for expanded liver transplant eligibility — allowing more patients with HCC to benefit from transplantation
As a core member of this team, Dr. Sun has been trained in and practices the surgical standards that have made Zhongshan Hospital's liver program internationally renowned.
Hepatobiliary Surgery: Dr. Sun's Scope of Practice
Dr. Sun's 2,000+ surgical cases span the full spectrum of hepatobiliary surgery:
Liver Cancer (HCC) Resection
- Anatomical hepatectomy: Resection along portal territory boundaries — the Zhongshan standard for minimizing intrahepatic recurrence
- Major hepatectomy: Right hepatectomy, left hepatectomy, extended hepatectomy for large or multifocal tumors
- Laparoscopic hepatectomy: Minimally invasive resection for appropriate tumor locations
- Repeat hepatectomy: Re-resection for intrahepatic HCC recurrence — a Zhongshan specialty given the team's long-term follow-up data
- Conversion surgery: Resection after successful downstaging with TACE, HAIC, or systemic therapy
Liver Transplantation
- Liver transplantation for HCC within Milan and Hangzhou Criteria
- Coordination with the transplant program for deceased donor and living donor procedures
- Post-transplant HCC recurrence surveillance and management
Benign Hepatobiliary Tumors
- Hepatic hemangioma — resection for large or symptomatic lesions
- Focal nodular hyperplasia and hepatocellular adenoma
- Liver cysts — fenestration or resection
Biliary Surgery
- Intrahepatic cholangiocarcinoma resection
- Hilar cholangiocarcinoma (Klatskin tumor) — complex biliary reconstruction
- Bile duct stones and strictures
Research: Liver Cancer Metastasis and Recurrence Mechanisms
Dr. Sun's research program focuses on understanding why liver cancer recurs and metastasizes after surgery — the central challenge in improving long-term survival after curative resection. His important discoveries in this area have implications for:
- Identifying high-risk patients for recurrence after surgery — enabling more intensive surveillance and earlier intervention
- Developing adjuvant treatment strategies to reduce recurrence risk — informing the use of post-operative targeted therapy, immunotherapy, or TACE
- Understanding the biology of early vs. late recurrence — early recurrence (≤2 years) reflects residual micrometastatic disease from the primary tumor; late recurrence (>2 years) reflects de novo tumor formation in the cirrhotic liver
- Identifying molecular targets for novel therapies to prevent or treat recurrence
This research background means that Dr. Sun's surgical patients benefit from post-operative management strategies informed by the latest understanding of recurrence biology — not just standard follow-up protocols.
How CMCS Coordinates Your Care
China Medical Concierge Shanghai (CMCS) is a health management company — not a hospital. We connect international patients with Shanghai's leading liver cancer surgeons, including Dr. Sun Yunfan at Zhongshan Hospital, and manage every step of the process:
- Review of existing liver imaging (MRI with hepatobiliary contrast, CT, PET-CT), tumor markers (AFP, AFP-L3, DCP), liver function tests, and prior treatment records
- Surgical resectability assessment with Dr. Sun's team within the Fan Jia program
- Coordination with interventional oncology for pre-operative downstaging or bridging therapy
- Coordination with medical oncology for adjuvant systemic therapy planning
- Appointment scheduling with priority access
- Medical interpretation during consultations and multidisciplinary tumor board discussions
- Logistics support: accommodation near Zhongshan Hospital, visa assistance, and local transport
- Post-operative follow-up and remote monitoring coordination
Get in Touch
If you have liver cancer or another hepatobiliary condition and are seeking surgical evaluation at China's premier liver cancer center, contact our team for a confidential consultation.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0件のコメント